Brief: VIVA Biotech Holdings Posts H1 Revenue Of RMB981.8 Mln
29/08/2024 11:10
Aug 29 (Reuters) - VIVA Biotech Holdings H1 capex RMB 82.7 million. * H1 revenue RMB 981.8 million * H1 net income RMB 144.2 million * H1 gross profit RMB 339.1 million
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical